ArticleBMC psychiatry2021
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression.
Kinza Degerlund Maldi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it